Research ArticleIssues in Dental Hygiene Practice

A Review of Oral Chronic Graft-Versus-Host Disease: Considerations for dental hygiene practice

Lisa Bennett Johnson, Uhlee Oh, Marilynn Rothen, Herve Y. Sroussi, David R Dean, C. Michele Lloid, Katelyn Cintron, Stephanie J. Lee, Corey S. Cutler and Nathaniel S. Treister
American Dental Hygienists' Association April 2022, 96 (2) 6-17;

References

  1. 1.↵
    1. Juric MK,
    2. Ghimire S,
    3. Ogonek J, et al.
    Milestones of hematopoietic stem cell transplantation - from first human studies to current developments. Front Immunol. 2016 Nov; 7:470.
    OpenUrlCrossRef
  2. 2.↵
    1. Phelan R,
    2. Arora, M.,
    3. Chen, M.
    Current use and outcome of hematopoietic stem cell transplantation: CIBMTR US summary slides. Center for International Blood & Bone Marrow Transplant Research, 2020.
  3. 3.↵
    1. D’Souza A,
    2. Lee S,
    3. Zhu X,
    4. Pasquini M.
    Current use and trends in hematopoietic cell transplantation in the United States. Biol Blood Marrow Transplant. 2017 Sep;23(9):1417-21.
    OpenUrl
  4. 4.↵
    1. Gooley TA,
    2. Chien JW,
    3. Pergam SA, et al.
    Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2010 Nov;363(22):2091-101.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.
    1. Wingard JR,
    2. Majhail NS,
    3. Brazauskas R, et al.
    Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol. 2011 Jun;29(16):2230-9.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Martin PJ,
    2. Counts GW, Jr.,
    3. Appelbaum FR, et al.
    Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. J Clin Oncol. 2010 Feb;28(6):1011-6.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Jagasia MH,
    2. Greinix HT,
    3. Arora M, et al.
    National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: the 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant. 2015 Mar;21(3):389-401.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Georges GE,
    2. Bar M,
    3. Onstad L, et al.
    Survivorship after autologous hematopoietic cell transplantation for lymphoma and multiple myeloma: late effects and quality of life. Biol Blood Marrow Transplant. 2020 Feb(2):407-12.
  9. 9.↵
    1. Majhail NS,
    2. Rizzo JD,
    3. Lee SJ, et al.
    Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2012 Mar;18(3):348-71.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Léger CS,
    2. Nevill TJ.
    Hematopoietic stem cell transplantation: a primer for the primary care physician. CMAJ. 2004 May;170(10):1569-77.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Jenq RR,
    2. van den Brink MRM.
    Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer. Nat Rev Cancer. 2010 Mar;(3):213-21.
  12. 12.↵
    1. Martinez-Cibrian N,
    2. Zeiser R,
    3. Perez-Simon JA.
    Graft-versus-host disease prophylaxis: pathophysiology-based review on current approaches and future directions. Blood Rev. 2021 Jul;48.
  13. 13.↵
    1. Elad S,
    2. Raber-Durlacher JE,
    3. Brennan MT, et al.
    Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT). Support Care Cancer. 2015 Jan;23(1):223-36.
    OpenUrl
  14. 14.↵
    1. Chaudhry HM,
    2. Bruce AJ,
    3. Wolf RC, et al.
    The incidence and severity of oral mucositis among allogeneic hematopoietic stem cell transplantation patients: a systematic review. Biol Blood Marrow Transplant. 2016 Apr;22(4):605-16.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Rankin KV,
    2. Epstein J,
    3. Huber MA, et al.
    Oral health in cancer therapy. Tex Dent J 2009 May;126(5):389-97, 406-19, 422-37.
    OpenUrlPubMed
  16. 16.↵
    1. Arora M,
    2. Klein JP,
    3. Weisdorf DJ, et al.
    Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis. Blood. 2011 Jan;117(24):6714-20.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Meier JKH,
    2. Wolff D,
    3. Pavletic S, et al.
    Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD. Clin Oral Investig. 2011 Apr(2):127-39.
  18. 18.↵
    1. Lee SJ.
    Classification systems for chronic graft-versus-host disease. Blood. 2017 Jan;129(1):30-7.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Majhail NS,
    2. Tao L,
    3. Bredeson C, et al.
    Prevalence of hematopoietic cell transplant survivors in the United States. Biol Blood Marrow Transplant. 2013 Oct;19(10):1498-501.
    OpenUrl
  20. 20.↵
    1. Lee SJ,
    2. Wolff D,
    3. Kitko C, et al.
    Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. the 2014 response criteria working group report. Biol Blood Marrow Transplant. 2015 Jun;21(6):984-99.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Bar M,
    2. Sandmaier B,
    3. Inamoto Y, et al.
    Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose. Biol Blood Marrow Transplant. 2013 Jun;19(6):949-57.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Zecca M,
    2. Prete A,
    3. Rondelli R, et al.
    Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome. Blood. 2002 Aug 15;100(4):1192-200.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Vogelsang GB,
    2. Lee L,
    3. Bensen-Kennedy DM.
    Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant. Annu Rev Med. 2003;54:29-52.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Tiercy JM.
    HLA-C incompatibilities in allogeneic unrelated hematopoietic stem cell transplantation. Front Immunol. 2014 May;5:216.
    OpenUrlPubMed
  25. 25.
    1. Carreras E,
    2. Dufour C,
    3. Mohty M,
    4. Kröger N
    1. Wolff D,
    2. Lawitschka A.
    Chronic graft-versus-host disease. In: Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies. 7th ed. Cham (CH): Springer; 2019. Chapter 44, Chronic Graft-Versus-Host Disease; p. 331-45.
  26. 26.↵
    1. Ferrara JL,
    2. Reddy P.
    Pathophysiology of graft-versus-host disease. Semin Hematol. 2006 Jan;43(1):3-10.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Cooke KR,
    2. Luznik L,
    3. Sarantopoulos S, et al.
    The biology of chronic graft-versus-host disease: a task force report from the National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2017 Feb;23(2):211-34.
    OpenUrl
  28. 28.↵
    1. Arai S,
    2. Jagasia M,
    3. Storer B, et al.
    Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH consensus criteria. Blood. 2011 Oct;118(15):4242-9.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Lee SJ,
    2. Flowers ME.
    Recognizing and managing chronic graft-versus-host disease. Hematology Am Soc Hematol Educ Program. 2008:134-41.
  30. 30.↵
    1. Mays JW,
    2. Fassil H,
    3. Edwards DA, et al.
    Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research. Oral Dis. 2013 May;19(4):327-46.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Treister N,
    2. Duncan C,
    3. Cutler C,
    4. Lehmann L.
    How we treat oral chronic graft-versus-host disease. Blood. 2012 Oct;120(17):3407-18.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Treister N,
    2. Chai X,
    3. Kurland B, et al.
    Measurement of oral chronic GVHD: results from the chronic GVHD consortium. Bone Marrow Transplant. 2013 Aug;48(8):1123-8.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Fassil H,
    2. Bassim CW,
    3. Mays J, et al.
    Oral chronic graft-vs.-host disease characterization using the NIH scale. J Dent Res. 2012 Jul;91(7 Suppl):45s-51s.
    OpenUrl
  34. 34.↵
    1. Carpenter PA,
    2. Kitko CL,
    3. Elad S, et al.
    National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. the 2014 ancillary therapy and supportive care working group report. Biol Blood Marrow Transplant. 2015 Jul;21(7):1167-87.
    OpenUrl
  35. 35.↵
    1. Hseih R,
    2. de Souza, MM,
    3. de Paula, F, et al.
    Oral chronic graft-versus-host disease: a short review. Trends transplant. 2016 Jan; 91(1):1-4.
    OpenUrl
  36. 36.↵
    1. Schubert MM,
    2. Correa ME.
    Oral graft-versus-host disease. Dent Clin North Am. 2008 Jan;52(1):79-109.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Curtis RE,
    2. Rowlings PA,
    3. Deeg HJ, et al.
    Solid cancers after bone marrow transplantation. N Engl J Med. 1997 Mar;336(13):897-904.
    OpenUrlCrossRefPubMedWeb of Science
  38. 38.↵
    1. Rizzo JD,
    2. Curtis RE,
    3. Socié G, et al.
    Solid cancers after allogeneic hematopoietic cell transplantation. Blood. 2009 Jan 29;113(5):1175-83.
    OpenUrlAbstract/FREE Full Text
  39. 39.↵
    1. Haverman TM,
    2. Raber-Durlacher JE,
    3. Raghoebar, II, et al.
    Oral chronic graft-versus-host disease: what the general dental practitioner needs to know. J Am Dent Assoc. 2020 Nov;151(11):846-56.
    OpenUrlPubMed
  40. 40.↵
    1. Dowd FJ.
    Saliva and dental caries. Dent Clin North Am. 1999 Oct;43(4):579-97.
    OpenUrlPubMed
  41. 41.↵
    1. Selwitz RH,
    2. Ismail AI,
    3. Pitts NB.
    Dental caries. Lancet. 2007 Jan 6;369(9555):51-9.
    OpenUrlCrossRefPubMedWeb of Science
  42. 42.↵
    1. Mawardi H,
    2. Hashmi SK,
    3. Elad S, et al.
    Chronic graft-versus-host disease: Current management paradigm and future perspectives. Oral Dis. 2019 May(4):931-48.
  43. 43.↵
    1. Mawardi H,
    2. Elad S,
    3. Correa ME, et al.
    Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes. Bone Marrow Transplant. 2011 Jun;46(6):884-91.
    OpenUrlCrossRefPubMed
  44. 44.↵
    1. Bassim CW,
    2. Fassil H,
    3. Mays JW, et al.
    Validation of the National Institutes of Health chronic GVHD oral mucosal score using component-specific measures. Bone Marrow Transplant. 2014 Jan(1):116-21.
  45. 45.↵
    1. Gomes AO,
    2. Torres SR,
    3. Maiolino A, et al.
    Early and late oral features of chronic graft-versus-host disease. Rev Bras Hematol Hemoter. 2014 Jan-Feb;36(1):43-9.
    OpenUrl
  46. 46.↵
    1. Bollero P,
    2. Passarelli PC,
    3. D’Addona A, et al.
    Oral management of adult patients undergoing hematopoietic stem cell transplantation. Eur Rev Med Pharmacol Sci. 2018 Feb;22(4):876-87.
    OpenUrlPubMed
  47. 47.↵
    1. Ashe TE,
    2. Elter JR,
    3. Southerland JH, et al.
    North Carolina dental hygienists’ assessment of patients’ tobacco and alcohol use. J Dent Hyg. 2005 Spring;79(2):9.
    OpenUrlFREE Full Text
  48. 48.↵
    1. Kuten-Shorrer M,
    2. Woo SB,
    3. Treister NS.
    Oral graft-versus-host disease. Dent Clin North Am. 2014 Apr;58(2):351-68.
    OpenUrl
  49. 49.↵
    1. Lewis MAO,
    2. Williams DW.
    Diagnosis and management of oral candidosis. Br Dent J. 2017 Nov;223(9):675-81.
    OpenUrl
  50. 50.↵
    1. Quindós G,
    2. Gil-Alonso S,
    3. Marcos-Arias C, et al.
    Therapeutic tools for oral candidiasis: current and new antifungal drugs. Med Oral Patol Oral Cir Bucal. 2019 Mar;24(2):e172-80.
    OpenUrl
  51. 51.↵
    1. Singhal S,
    2. Powles R,
    3. Treleaven J, et al.
    Pilocarpine hydrochloride for symptomatic relief of xerostomia due to chronic graft-versus-host disease or total-body irradiation after bone-marrow transplantation for hematologic malignancies. Leuk Lymphoma. 1997 Feb;24(5-6):539-43.
    OpenUrlCrossRefPubMed
  52. 52.↵
    1. Couriel D,
    2. Carpenter PA,
    3. Cutler C, et al.
    National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. the 2014 ancillary therapy and supportive care working group report. Biol Blood Marrow Transplant. 2006 Apr;12(4):375-96.
    OpenUrlCrossRefPubMedWeb of Science
  53. 53.↵
    1. Carpenter PA,
    2. Schubert MM,
    3. Flowers ME.
    Cevimeline reduced mouth dryness and increased salivary flow in patients with xerostomia complicating chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2006 Jul;12(7):792-4.
    OpenUrlCrossRefPubMed
  54. 54.↵
    1. Von der Fehr FR,
    2. Löe H,
    3. Theilade E.
    Experimental caries in man. Caries Res. 1970;4(2):131-48.
    OpenUrlCrossRefPubMed
  55. 55.↵
    1. Moynihan P,
    2. Petersen PE.
    Diet, nutrition, and the prevention of dental diseases. Public Health Nutr. 2004 Feb;7(1a):201-26.
    OpenUrlCrossRefPubMedWeb of Science
  56. 56.↵
    1. Castellarin P,
    2. Stevenson K,
    3. Biasotto M, et al.
    Extensive dental caries in patients with oral chronic graft-versus-host disease. Biol Blood Marrow Transplantation. 2012 Oct;18(10):1573-79.
    OpenUrlCrossRefPubMed
  57. 57.↵
    1. Weyant RJ,
    2. Tracy SL,
    3. Anselmo TT, et al.
    Topical fluoride for caries prevention: executive summary of the updated clinical recommendations and supporting systematic review. J Am Dent Assoc. 2013 Nov;144(11):1279-91.
    OpenUrlAbstract/FREE Full Text
  58. 58.↵
    1. Featherstone JDB,
    2. Chaffee BW.
    The evidence for caries management by risk assessment (CAMBRA®). Adv Dent Res. 2018 Feb;29(1):9-14
    OpenUrl
  59. 59.↵
    1. Slayton RL,
    2. Urquhart O,
    3. Araujo MWB, et al.
    Evidence-based clinical practice guideline on nonrestorative treatments for carious lesions: a report from the American Dental Association. J Am Dent Assoc. 2018 Oct;149(10):837-49.
    OpenUrlCrossRef
  60. 60.↵
    1. Contreras V,
    2. Toro MJ,
    3. Elías-Boneta AR,
    4. Encarnación-Burgos A.
    Effectiveness of silver diamine fluoride in caries prevention and arrest: a systematic literature review. Gen Dent. 2017 May-Jun;65(3):22-9.
    OpenUrl
  61. 61.↵
    1. Bernabé E,
    2. Vehkalahti MM,
    3. Sheiham A, et al.
    Sugar-sweetened beverages and dental caries in adults: a 4-year prospective study. J Dent. 2014 Aug;42(8):952-8.
    OpenUrlCrossRefPubMed
  62. 62.↵
    1. Young DA,
    2. Lyon L,
    3. Azevedo S.
    The role of dental hygiene in caries management: a new paradigm. J Dent Hyg. 2010 Summer;84(3):121-9.
    OpenUrlFREE Full Text
  63. 63.↵
    1. Reed DN,
    2. Hall DL,
    3. Cottle JH, et al.
    Dental management of scleroderma patients using pentoxifylline plus vitamin E with and without TheraBite(®) to reduce trismus: two case reports and brief review of literature. Clin Case Rep. 2020 Jan 17;8(2):247-53.
    OpenUrl
  64. 64.↵
    1. Tolle SL.
    Scleroderma: considerations for dental hygienists. Int J Dent Hyg. 2008 May;6(2):77-83.
    OpenUrlPubMed
  65. 65.↵
    1. Poole J,
    2. Conte C,
    3. Brewer C, et al.
    Oral hygiene in scleroderma: the effectiveness of a multi-disciplinary intervention program. Disabil Rehabil. 2010;32(5):379-84.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
A Review of Oral Chronic Graft-Versus-Host Disease: Considerations for dental hygiene practice
Lisa Bennett Johnson, Uhlee Oh, Marilynn Rothen, Herve Y. Sroussi, David R Dean, C. Michele Lloid, Katelyn Cintron, Stephanie J. Lee, Corey S. Cutler, Nathaniel S. Treister
American Dental Hygienists' Association Apr 2022, 96 (2) 6-17;
del.icio.us logo Twitter logo Facebook logo Mendeley logo

Jump to section

Similar Articles

Related Articles

  • No related articles found.

Keywords